EGFR

Epidermal Growth Factor Receptor (EGFR) is a type of trans-membrane protein which is expressed on the surface of cells. It is involved in the regulation of a wide variety of cellular processes, including but not limited to cell proliferation, differentiation, and migration. It has been widely studied in cancer research due to its role in tumor growth, metastasis and angiogenesis. The activation of EGFR is associated with the activation of other signaling pathways, leading to changes in gene expression, which can affect cell functions. As a result, it has become an important target in several drugs used to treat cancer, such as Erbitux and Tarceva. In addition, due to its role in normal cell development, it is also a useful tool for studying embryonic development and for regenerative medicine.

← Journal of Pancreas

Related Articles

1 journal(s) found

Pancreas

ISSN: Coming Soon
Type: Open Access Journal
Editor: Giuseppe Maulucci, Assistant professor, Catholic University Medical School, Rome.
JPA concentrates on the entire spectrum of the pancreatic gland aspects: normal function, etiology, epidemiology, prevention, genetics, pathophisiology, diagnosis, surgical and medical management of pancreatic diseases including cancer, inflammatory diseases, diabetes mellitus, cystic fibrosis and other congenital disorders.